Negative rating slashes 10% from Intuitive Surgical | Wall Street Beat Wall Street Beat

A research report blasting Intuitive Surgical (NSDQ:ISRG) spooked investors on Wall Street yesterday and today, prompting a selloff that’s shaved some 11% from the medical device company’s share price.

Citron Research, citing several factors that investors had ignored, said yesterday that it expects ISRG shares to drop to $350 over the next year and as low as $250 over the next 18 months.

ISRG shares began yesterday at $547.33 each, but as The Street digested the Citron report unusually heavy trading plunged the stock to a $515.45 close, down 5.7% on the day. Shares opened today at $508.82 and slipped another 5.3% to close at $488.31 apiece.

Sign up to get our free newsletters delivered straight to your inbox

The Citron researchers said the stock’s high earnings multiple belies "a track record of excessive and unjustified marketing claims, the utter lack of clinical evidence of superior medical outcomes when using its product for surgery, and the gathering storm of legal liability accruing to the company due to its failure to adequately disclose risks prior to its technology causing adverse surgical outcomes, scattered among the hundreds of thousands of surgeries performed with its robotic surgery devices," according to their report (PDF).

"Intuitive Surgical (ISRG) is unique because the da Vinci is a product that has not been sold to meet patient need, as most medical devices are, but rather it has been sold using fear to hospital management purchasing committees. Aggressive salespeople have escalated a ‘medical arms race’ into high technology, regardless of whether surgeries with this device produce significant medical benefit or not," the researchers wrote, citing key developments over the past 4 weeks:

  • “Three new, highly credible lawsuits over hysterectomies with bad outcomes have been filed – in addition to 6 really ominous ones from earlier in the year.”
  • "Large insider sales. Within the last month, chairman Lonnie Smith sold shares from options exercise (not 10(5)b) netting over $50 million, a rather large percentage of his recently apportioned stake."
  • “Peer criticism – a number of recent articles summarizing from highly credible, recent studies that highlight the gap between the company marketing materials’ claims and full scientific disclosure of the true risks and differentials in medical outcomes. This gap creates the basis for legal challenges to the company due to inadequate disclosure of the risks of bad outcomes.”
  • "Further skepticism about the true cost/benefit of robotic surgeries."
  • "Indications of loss of morale and sharp erosion of confidence in management and oversaturation coming through the sales force."

And that’s not all, at least according to Citron, citing a "severe vacuum of real scientific evidence" backing use of the da Vinci system.

"The most serious issue facing Intuitive is that, while its deployment is well past the 10-year point into mainstream healthcare in the U.S., there is still a severe vacuum of real scientific evidence that the da Vinci is of any clinical benefit, when the full arc of costs and outcomes are weighed, in the most commonly performed surgeries in which it is utilized. While this is not a new thought, the current legal cases will bring this issue to the forefront," according to the researchers.

 Allergan closes Skinmedica buyout
Allergan (NYSE:AGN) said it’s closed its $350 million acquisition of SkinMedica’s topical aesthetics skin care business.
Read more

 Winner Medical goes private
Chinese medical dressings maker Winner Medical Group (NSDQ:WWIN) closed its "going private transaction" Dec. 11, paying $4.50 per share to its former stockholders.
Read more

 Lombard Medical extends funding round
Lombard Medical Technologies (LON:LMT) said it’s extending its funding round by 6 months, until June 30, 2013, for the 2nd tranche worth a hoped-for £14.1 million (about $23.0 million). MVM Life Science Partners is backing out of the deal, replaced by LSP Life Sciences Fund.
Read more

 PatientSafe, Lumo Body Tech, Ortho Kinematics drum up investors

mHealth company PatientSafe Solutions drummed up $13.3 million of a hoped-for $25.7 million; Lumo Body Tech raised $5 million for its Lumoback posture sensor; and spine imaging informatics firm Ortho Kinematics pulled in more than $2 million in a Series B round.

Read some more

 Analysts’ ups and downs

  • Abbott (NYSE:ABT): William Blair & Co. initiates coverage with "outperform" rating.
  • Conceptus (NSDQ:CPTS): Stifel Nicolaus initiates coverage with "buy" rating, $26 price target.
  • Cytomedix (OTC:CMXI): LifeSci Advisors initiates coverage.
  • Henry Schein (NSDQ:HSIC): Stifel Nicolaus initiates coverage with "hold" rating.
  • Stryker (NYSE:SYK): Standpoint Research cuts to "hold" from "buy" rating.

RSS From Medical Design & Outsourcing

  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]
  • Saelig introduces Multiple Instrument System MIS4 universal test system
    Saelig Company has introduced the ABI Electronics’ Multiple Instrument Station MIS4, an all-in-one testing tool that provides all commonly required test instruments in one compact programmable hardware module, mounted in a compact case or installed in a PC-drive bay. Controlled by ABI’s sophisticated SYSTEM 8 Ultimate PC software with a simple yet programmable operator interface, […]
  • AssurX announces document management software update for small to mid-size companies in FDA regulated industries
    AssurX, an enterprise quality management, risk and regulatory compliance solution provider, announces the release of the latest update to their AssurX document management software. The document management solution provides a cost-effective solution for small to medium sized companies faced with streamlined operations and is fully compliant for FDA regulated industries. Ideal solution for small to […]
  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]

Leave a Reply